Global Insulin Pumps Patent Landscape Report 2024

Patent Landscape Report Coverage

The Global Insulin Pumps Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for insulin pumps include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with insulin pumps. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within insulin pump technologies.

Key Inclusions:

Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for insulin pump technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with Insulin Pumps.

Analysis of Patent Applications

A comprehensive summary of several patent applications for insulin pumps filed across different jurisdictions and their relative value is covered. The analysis will cover the capital in terms of innovation and innovation type.

Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for insulin pumps and their relative value in the IP are covered in the final report.

What are Insulin Pumps?

An insulin pump is a small, wearable medical device that delivers a consistent and controlled dose of insulin to diabetics. It simulates the function of a healthy pancreas by delivering a consistent basal rate of insulin throughout the day and night, as well as supplemental bolus doses during meals or to address high blood sugar. The pump comprises of a small insulin reservoir coupled to a thin tube called a cannula that is implanted beneath the skin. By providing accurate and adjustable insulin delivery, the pump aids improve blood sugar management and gives greater flexibility than traditional insulin injections.

Insulin Pumps Industry Growth Drivers

Growing Incidence of Diabetes is Expected to Boost the Patent Industry Growth

The incidences of diabetes are increasing rapidly in both emerging and industrialized countries. Several factors contribute to this, including obesity and sedentary lifestyle, among others. As a result, the growing elderly population raises the risk of age-related diseases such cataracts, glaucoma, hypertension, and diabetes. For example, the Endocrine Society estimates that by 2022, 33% of persons aged 65 and up would have diabetes. Furthermore, the growing number of persons suffering from type 1 diabetes worldwide creates a big pool of patients who require insulin to manage the disease. High-income countries have a higher prevalence of type 1 diabetes than low- and middle-income countries. These people require insulin injections on a daily basis. Thus, increased awareness of these pumps among diabetes patients, as well as the benefits associated with disease management, are expected to fuel market expansion throughout the forecast period.

Rising Investment in R&D and Product Approvals is Expected to Propel Insulin Pumps Patent Industry

The growing popularity of these pumps among diabetics in developing nations is pushing market players to focus on the R&D of technologically sophisticated products and introduce new items to the market. These R&D efforts were accompanied by several clinical trials, which found evidence of sustained improvement in glycemic control in type 2 diabetes patients on pump therapy compared to those on MDI therapy. Furthermore, a strong pipeline of goods in development and under review contributes to market growth. Medtronic, Insulet Corporation, Embecta, and others are among the companies that intend to launch breakthrough solutions in the coming years.

Insulin Pumps Patent Segmentation

Insulin Pumps Patent Segmentation Analysis

The breakup based on product type includes insulin pumps along with insulin pump supplies and accessories. Insulin patch pumps are superior insulin delivery devices because they are more discrete, smaller, and easier to use than regular insulin pumps. Insulin patch pumps are less expensive than regular insulin pumps, leading to increased demand.

Insulin Pumps Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for insulin pump patents, having around 117,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with Insulin Pumps patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the insulin pumps field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Genentech Inc.

A biotechnology business that was established in 1976 and has its main office in South San Francisco, California, is a pioneer in the creation and production of biopharmaceuticals. The company uses cutting-edge virus filtration technologies to ensure product safety and specializes in the discovery and production of medications for severe medical conditions. Genentech is renowned for its excellent biologics strategies, especially in the fields of neuroscience, immunology, and oncology.

Dexcom Inc.

The company has its headquarters in San Diego, California, and was established in 1999. It is a prominent lead...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other companies include Medtronic Minimed Inc., Abbott Diabetes Care Inc., and Bigfoot Biomedical Inc., among others.

Reasons to Purchase this Report

The insulin pumps patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of insulin pumps.
• Innovation Insights: The patent analysis reveals new innovations and technologies in insulin pumps.
• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the insulin pumps patent landscape.
• Risk Assessment: In technology-intensive fields such as insulin pumps, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Insulin Pumps Patent Landscape Report

• Who are the key players in the insulin pumps patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in insulin pumps patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the insulin pumps industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in insulin pumps?
• What are the challenges and opportunities in the insulin pumps patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in insulin pumps?

Related Reports

Global Human Insulin Market

Global Insulin Pen Market

Asia Pacific Biosimilar Insulin Glargine and Lispro Market